Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study (Q44472887)

3 December 2017

Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study (English)

1 reference

Hormone Replacement Therapy

3 December 2017

1 reference

1 reference

1 reference

J J Sidelmann

1

1 reference

3 December 2017

J Jespersen

2

1 reference

3 December 2017

L F Andersen

3

1 reference

3 December 2017

S O Skouby

4

1 reference

3 December 2017

Prospective Collaborative Danish Climacteric Study

5

1 reference

3 December 2017

1 June 2003

1 reference

BJOG: an International Journal of Obstetrics and Gynaecology

3 December 2017

1 reference

3 December 2017

110

1 reference

3 December 2017

6

1 reference

3 December 2017

541-547

1 reference

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

3 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

Risk of venous thromboembolism in users of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

Estrogen replacement therapy and coagulation: relationship to lipid and lipoprotein changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

Factor V Leiden, Hormone Replacement Therapy, and Risk of Venous Thromboembolic Events in Women With Coronary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-0528.2003.02165.X

10.1046/J.1471-0528.2003.02165.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference